Anaplastic thyroid cancer. Is there a light at the end of the tunnel?

Anaplastic thyroid cancer is one of the most prognostically unfavorable tumors. This disadvantage traditionally consisted of a rapid increase in the size of the primary tumor with a tendency to the development of asphyxia and the rapid appearance of distant metastases, as well as a poor response to...

Full description

Saved in:
Bibliographic Details
Main Authors: A. L. Pylev, A. A. Zhandarova, K. S. Petrov, D. S. Romanov, V. A. Lisovoy, S. V. Golub
Format: Article
Language:Russian
Published: ABV-press 2020-04-01
Series:Опухоли головы и шеи
Subjects:
Online Access:https://ogsh.abvpress.ru/jour/article/view/471
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850024164525604864
author A. L. Pylev
A. A. Zhandarova
K. S. Petrov
D. S. Romanov
V. A. Lisovoy
S. V. Golub
author_facet A. L. Pylev
A. A. Zhandarova
K. S. Petrov
D. S. Romanov
V. A. Lisovoy
S. V. Golub
author_sort A. L. Pylev
collection DOAJ
description Anaplastic thyroid cancer is one of the most prognostically unfavorable tumors. This disadvantage traditionally consisted of a rapid increase in the size of the primary tumor with a tendency to the development of asphyxia and the rapid appearance of distant metastases, as well as a poor response to the recommended treatment methods. The result of many years of efforts by oncologists around the world were several treatment regimens, including an ideal amount of surgical intervention, chemotherapy and radiation therapy, but the effectiveness of this treatment, as well as the patient’s life expectancy after it, could not be called satisfactory. Improving the understanding of the molecular genetic characteristics of tumors, including anaplastic thyroid cancer, provided us with information on two possible features of the genetic apparatus of tumor cells that can have clinical significance: V600E mutations in the BRAF gene and fusion of NTRK genes. The clinical example described in this article is probably the first Russian illustration of the effectiveness of anti-BRAF therapy in a patient with anaplastic thyroid cancer. From our point of view, the benefit of this example is not only to demonstrate the effectiveness of modern targeted therapy, but also the need not to abandon other treatment methods, in this case, radiation therapy to the area of the primary tumor (and by analogy with this, surgical removal of the thyroid tumor glands in case of its resectability).
format Article
id doaj-art-e96d5a999a5a4311998bd66915d4192c
institution DOAJ
issn 2222-1468
2411-4634
language Russian
publishDate 2020-04-01
publisher ABV-press
record_format Article
series Опухоли головы и шеи
spelling doaj-art-e96d5a999a5a4311998bd66915d4192c2025-08-20T03:01:11ZrusABV-pressОпухоли головы и шеи2222-14682411-46342020-04-01101101910.17650/2222-1468-2020-10-1-10-19377Anaplastic thyroid cancer. Is there a light at the end of the tunnel?A. L. Pylev0A. A. Zhandarova1K. S. Petrov2D. S. Romanov3V. A. Lisovoy4S. V. Golub5Center for Innovative Medical TechnologiesCenter for Innovative Medical TechnologiesМedscanCenter for Innovative Medical Technologies; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaCenter for Innovative Medical TechnologiesМedscanAnaplastic thyroid cancer is one of the most prognostically unfavorable tumors. This disadvantage traditionally consisted of a rapid increase in the size of the primary tumor with a tendency to the development of asphyxia and the rapid appearance of distant metastases, as well as a poor response to the recommended treatment methods. The result of many years of efforts by oncologists around the world were several treatment regimens, including an ideal amount of surgical intervention, chemotherapy and radiation therapy, but the effectiveness of this treatment, as well as the patient’s life expectancy after it, could not be called satisfactory. Improving the understanding of the molecular genetic characteristics of tumors, including anaplastic thyroid cancer, provided us with information on two possible features of the genetic apparatus of tumor cells that can have clinical significance: V600E mutations in the BRAF gene and fusion of NTRK genes. The clinical example described in this article is probably the first Russian illustration of the effectiveness of anti-BRAF therapy in a patient with anaplastic thyroid cancer. From our point of view, the benefit of this example is not only to demonstrate the effectiveness of modern targeted therapy, but also the need not to abandon other treatment methods, in this case, radiation therapy to the area of the primary tumor (and by analogy with this, surgical removal of the thyroid tumor glands in case of its resectability).https://ogsh.abvpress.ru/jour/article/view/471anaplastic thyroid cancer, mutation in the braf gene, dabrafenib, trametinib, targeted therapy
spellingShingle A. L. Pylev
A. A. Zhandarova
K. S. Petrov
D. S. Romanov
V. A. Lisovoy
S. V. Golub
Anaplastic thyroid cancer. Is there a light at the end of the tunnel?
Опухоли головы и шеи
anaplastic thyroid cancer, mutation in the braf gene, dabrafenib, trametinib, targeted therapy
title Anaplastic thyroid cancer. Is there a light at the end of the tunnel?
title_full Anaplastic thyroid cancer. Is there a light at the end of the tunnel?
title_fullStr Anaplastic thyroid cancer. Is there a light at the end of the tunnel?
title_full_unstemmed Anaplastic thyroid cancer. Is there a light at the end of the tunnel?
title_short Anaplastic thyroid cancer. Is there a light at the end of the tunnel?
title_sort anaplastic thyroid cancer is there a light at the end of the tunnel
topic anaplastic thyroid cancer, mutation in the braf gene, dabrafenib, trametinib, targeted therapy
url https://ogsh.abvpress.ru/jour/article/view/471
work_keys_str_mv AT alpylev anaplasticthyroidcanceristherealightattheendofthetunnel
AT aazhandarova anaplasticthyroidcanceristherealightattheendofthetunnel
AT kspetrov anaplasticthyroidcanceristherealightattheendofthetunnel
AT dsromanov anaplasticthyroidcanceristherealightattheendofthetunnel
AT valisovoy anaplasticthyroidcanceristherealightattheendofthetunnel
AT svgolub anaplasticthyroidcanceristherealightattheendofthetunnel